Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 27 | 2023 | 771 | 4.920 |
Why?
|
| Hernia, Inguinal | 15 | 2024 | 73 | 4.100 |
Why?
|
| Herniorrhaphy | 15 | 2024 | 90 | 3.620 |
Why?
|
| Peritoneal Dialysis | 4 | 2023 | 31 | 2.500 |
Why?
|
| Kidney Failure, Chronic | 5 | 2023 | 413 | 1.820 |
Why?
|
| Simulation Training | 7 | 2022 | 97 | 1.600 |
Why?
|
| Catheters, Indwelling | 4 | 2023 | 113 | 1.570 |
Why?
|
| Catheterization | 4 | 2023 | 237 | 1.300 |
Why?
|
| Quality of Life | 15 | 2024 | 1665 | 1.270 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 3 | 2015 | 9 | 1.270 |
Why?
|
| Recurrence | 6 | 2024 | 1142 | 1.160 |
Why?
|
| Hernia, Abdominal | 3 | 2021 | 14 | 1.090 |
Why?
|
| Obesity | 3 | 2024 | 966 | 1.040 |
Why?
|
| Surgical Mesh | 8 | 2023 | 122 | 1.010 |
Why?
|
| Peritoneum | 3 | 2023 | 57 | 0.960 |
Why?
|
| Edema | 2 | 2015 | 70 | 0.950 |
Why?
|
| Curriculum | 8 | 2022 | 567 | 0.890 |
Why?
|
| Abdominal Wall | 2 | 2020 | 30 | 0.840 |
Why?
|
| Gastroesophageal Reflux | 5 | 2022 | 122 | 0.780 |
Why?
|
| Cholecystectomy, Laparoscopic | 4 | 2022 | 54 | 0.720 |
Why?
|
| Internship and Residency | 5 | 2022 | 1041 | 0.700 |
Why?
|
| Rectus Abdominis | 2 | 2017 | 40 | 0.680 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 304 | 0.680 |
Why?
|
| Obesity, Morbid | 7 | 2022 | 233 | 0.620 |
Why?
|
| Treatment Outcome | 23 | 2023 | 8217 | 0.600 |
Why?
|
| Bariatric Surgery | 5 | 2022 | 195 | 0.600 |
Why?
|
| Surgeons | 4 | 2022 | 247 | 0.600 |
Why?
|
| Retrospective Studies | 24 | 2024 | 9022 | 0.580 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 65 | 0.560 |
Why?
|
| Fundoplication | 7 | 2022 | 78 | 0.560 |
Why?
|
| Pyloromyotomy | 3 | 2021 | 11 | 0.550 |
Why?
|
| Hernia, Hiatal | 3 | 2023 | 38 | 0.550 |
Why?
|
| Myotomy | 3 | 2021 | 27 | 0.540 |
Why?
|
| Omentum | 1 | 2016 | 73 | 0.540 |
Why?
|
| Genitalia, Male | 1 | 2015 | 24 | 0.530 |
Why?
|
| Genitalia, Female | 1 | 2015 | 25 | 0.530 |
Why?
|
| Genitalia | 1 | 2015 | 21 | 0.520 |
Why?
|
| Humans | 61 | 2024 | 89157 | 0.520 |
Why?
|
| Esophageal Achalasia | 3 | 2020 | 60 | 0.500 |
Why?
|
| Clinical Competence | 11 | 2022 | 780 | 0.500 |
Why?
|
| Natural Orifice Endoscopic Surgery | 3 | 2020 | 41 | 0.480 |
Why?
|
| Aged | 20 | 2024 | 19119 | 0.460 |
Why?
|
| Male | 34 | 2024 | 42309 | 0.450 |
Why?
|
| Scrotum | 1 | 2013 | 18 | 0.450 |
Why?
|
| Gastric Bypass | 3 | 2022 | 110 | 0.420 |
Why?
|
| Adult | 22 | 2024 | 26542 | 0.410 |
Why?
|
| Middle Aged | 25 | 2024 | 25910 | 0.400 |
Why?
|
| Esophageal Motility Disorders | 2 | 2022 | 16 | 0.390 |
Why?
|
| Deglutition Disorders | 2 | 2023 | 119 | 0.390 |
Why?
|
| Female | 30 | 2024 | 46078 | 0.380 |
Why?
|
| Pain, Postoperative | 5 | 2021 | 251 | 0.370 |
Why?
|
| Hernia, Umbilical | 2 | 2021 | 17 | 0.360 |
Why?
|
| Foreign Bodies | 2 | 2022 | 66 | 0.310 |
Why?
|
| Reoperation | 3 | 2021 | 598 | 0.300 |
Why?
|
| Stomach | 3 | 2016 | 111 | 0.290 |
Why?
|
| Catheterization, Peripheral | 1 | 2007 | 60 | 0.280 |
Why?
|
| Suture Techniques | 3 | 2016 | 140 | 0.270 |
Why?
|
| Operative Time | 2 | 2024 | 142 | 0.270 |
Why?
|
| Esophageal Sphincter, Lower | 3 | 2021 | 32 | 0.270 |
Why?
|
| Incisional Hernia | 3 | 2021 | 17 | 0.260 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 3660 | 0.260 |
Why?
|
| Postoperative Complications | 4 | 2020 | 2278 | 0.260 |
Why?
|
| Body Mass Index | 3 | 2024 | 771 | 0.250 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2022 | 157 | 0.230 |
Why?
|
| Barrett Esophagus | 2 | 2015 | 93 | 0.230 |
Why?
|
| Laparotomy | 3 | 2019 | 67 | 0.230 |
Why?
|
| Physicians | 2 | 2021 | 690 | 0.220 |
Why?
|
| Virtual Reality | 1 | 2022 | 24 | 0.200 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 13 | 0.200 |
Why?
|
| Weight Loss | 3 | 2022 | 225 | 0.190 |
Why?
|
| Gastroparesis | 1 | 2021 | 14 | 0.190 |
Why?
|
| Safety | 1 | 2021 | 149 | 0.190 |
Why?
|
| Biological Products | 1 | 2023 | 154 | 0.190 |
Why?
|
| Computer Simulation | 5 | 2022 | 1097 | 0.190 |
Why?
|
| Esophagoplasty | 1 | 2020 | 10 | 0.180 |
Why?
|
| Insufflation | 1 | 2020 | 10 | 0.180 |
Why?
|
| Esophagitis, Peptic | 1 | 2020 | 10 | 0.180 |
Why?
|
| Electric Impedance | 4 | 2021 | 110 | 0.180 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 188 | 0.180 |
Why?
|
| Cholecystitis | 1 | 2020 | 15 | 0.180 |
Why?
|
| Cholelithiasis | 1 | 2020 | 35 | 0.180 |
Why?
|
| Cholecystectomy | 1 | 2020 | 21 | 0.180 |
Why?
|
| Diverticulitis | 1 | 2019 | 9 | 0.170 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2021 | 126 | 0.170 |
Why?
|
| Jejunum | 2 | 2016 | 80 | 0.170 |
Why?
|
| Health Care Surveys | 1 | 2020 | 280 | 0.170 |
Why?
|
| Hernia, Ventral | 2 | 2017 | 24 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 2658 | 0.170 |
Why?
|
| Patient Care Management | 1 | 2019 | 30 | 0.170 |
Why?
|
| Teaching | 1 | 2020 | 147 | 0.170 |
Why?
|
| Perception | 1 | 2020 | 178 | 0.160 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 36 | 0.160 |
Why?
|
| Physicians, Primary Care | 1 | 2020 | 105 | 0.160 |
Why?
|
| Chronic Pain | 1 | 2020 | 162 | 0.150 |
Why?
|
| Common Bile Duct | 1 | 2017 | 20 | 0.150 |
Why?
|
| Self-Assessment | 1 | 2017 | 47 | 0.150 |
Why?
|
| Acute Disease | 2 | 2019 | 841 | 0.150 |
Why?
|
| Choledocholithiasis | 1 | 2017 | 15 | 0.150 |
Why?
|
| Prostatic Hyperplasia | 1 | 2018 | 91 | 0.150 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 45 | 0.140 |
Why?
|
| Hospitals, High-Volume | 1 | 2017 | 36 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2021 | 570 | 0.140 |
Why?
|
| Self Concept | 1 | 2017 | 133 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2020 | 341 | 0.140 |
Why?
|
| Dexamethasone | 1 | 2018 | 344 | 0.140 |
Why?
|
| Patient Safety | 1 | 2019 | 217 | 0.140 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 46 | 0.140 |
Why?
|
| Pain Measurement | 3 | 2020 | 328 | 0.140 |
Why?
|
| Equipment Safety | 1 | 2016 | 33 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 479 | 0.140 |
Why?
|
| Prospective Studies | 6 | 2022 | 4281 | 0.130 |
Why?
|
| Weight Reduction Programs | 1 | 2016 | 13 | 0.130 |
Why?
|
| Equipment Failure | 1 | 2016 | 121 | 0.130 |
Why?
|
| Hospitals, University | 1 | 2016 | 196 | 0.130 |
Why?
|
| Prostatectomy | 1 | 2019 | 476 | 0.130 |
Why?
|
| Esophagoscopy | 3 | 2020 | 90 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2019 | 2302 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2019 | 2864 | 0.130 |
Why?
|
| Gastroenterology | 1 | 2017 | 144 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2017 | 780 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 532 | 0.120 |
Why?
|
| Child | 2 | 2023 | 7154 | 0.120 |
Why?
|
| Time Factors | 3 | 2021 | 5331 | 0.120 |
Why?
|
| Contraindications | 1 | 2014 | 70 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 643 | 0.120 |
Why?
|
| Remission, Spontaneous | 1 | 2014 | 53 | 0.120 |
Why?
|
| Endoscopy | 3 | 2022 | 348 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 391 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 711 | 0.110 |
Why?
|
| Databases, Factual | 3 | 2021 | 851 | 0.100 |
Why?
|
| Esophagogastric Junction | 2 | 2021 | 34 | 0.090 |
Why?
|
| Swine | 2 | 2022 | 581 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6794 | 0.090 |
Why?
|
| Elective Surgical Procedures | 2 | 2021 | 126 | 0.090 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2022 | 192 | 0.090 |
Why?
|
| United States | 2 | 2021 | 6965 | 0.080 |
Why?
|
| Operating Rooms | 2 | 2022 | 129 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 2614 | 0.080 |
Why?
|
| Recovery of Function | 2 | 2019 | 292 | 0.070 |
Why?
|
| Abdomen | 1 | 2007 | 122 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2007 | 138 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 415 | 0.070 |
Why?
|
| Weight Gain | 2 | 2016 | 119 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2020 | 396 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3444 | 0.060 |
Why?
|
| Patient Selection | 3 | 2019 | 684 | 0.050 |
Why?
|
| Manometry | 1 | 2022 | 44 | 0.050 |
Why?
|
| Vitamin D | 2 | 2015 | 269 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 3776 | 0.050 |
Why?
|
| Bile Ducts | 1 | 2021 | 59 | 0.050 |
Why?
|
| Esophageal Neoplasms | 2 | 2015 | 332 | 0.050 |
Why?
|
| Splenectomy | 1 | 2021 | 82 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2022 | 69 | 0.050 |
Why?
|
| Hernia | 1 | 2021 | 23 | 0.050 |
Why?
|
| Pylorus | 1 | 2021 | 14 | 0.050 |
Why?
|
| Gastric Emptying | 1 | 2021 | 25 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 164 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 65 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2022 | 187 | 0.050 |
Why?
|
| Spleen | 1 | 2021 | 432 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2020 | 66 | 0.040 |
Why?
|
| Publishing | 1 | 2021 | 90 | 0.040 |
Why?
|
| Esophagus | 1 | 2020 | 106 | 0.040 |
Why?
|
| Disease Progression | 2 | 2015 | 1488 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 237 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2022 | 246 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 160 | 0.040 |
Why?
|
| Wound Closure Techniques | 1 | 2019 | 15 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 207 | 0.040 |
Why?
|
| Device Removal | 1 | 2021 | 168 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2020 | 229 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 47 | 0.040 |
Why?
|
| Stents | 1 | 2022 | 403 | 0.040 |
Why?
|
| Urinary Retention | 1 | 2018 | 42 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 150 | 0.040 |
Why?
|
| Patient Outcome Assessment | 1 | 2019 | 84 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 329 | 0.040 |
Why?
|
| General Surgery | 1 | 2020 | 235 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2017 | 16 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2021 | 447 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 320 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 1194 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 860 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 848 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 55 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 119 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 988 | 0.030 |
Why?
|
| Surgical Stomas | 1 | 2016 | 22 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2022 | 2479 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2018 | 358 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2020 | 351 | 0.030 |
Why?
|
| Granuloma | 1 | 1996 | 65 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2016 | 103 | 0.030 |
Why?
|
| Video Recording | 1 | 2016 | 203 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 302 | 0.030 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 34 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 91 | 0.030 |
Why?
|
| Coronary Disease | 1 | 1996 | 260 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 876 | 0.030 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2014 | 8 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 306 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 251 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 371 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 1996 | 234 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 5483 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 46 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 1996 | 206 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1837 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1670 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 473 | 0.030 |
Why?
|
| Animals | 2 | 2022 | 27330 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 461 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 447 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2016 | 352 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 1213 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1063 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1593 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1867 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 433 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 1996 | 2347 | 0.010 |
Why?
|
| Prevalence | 1 | 1996 | 1242 | 0.010 |
Why?
|